课题基金 / 基金详情

Task X18: Evaluation of Filovirus Vaccines

Task X18: Evaluation of Filovirus Vaccines
任务 X18：丝状病毒疫苗的评估
批准号：
9366292
负责人：
RANDI HORNBACK
金额：
$451.83万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-07-06 至 2018-07-05
来源：
https://reporter.nih.gov/project-details/9366292
关键词：
BioterrorismClinicalCommunicable DiseasesContractsDevelopmentDrug resistanceEbola VaccinesEmerging Communicable DiseasesEvaluationFeasibility StudiesFilovirusPhaseSamplingServicesTestingToxicity TestsVaccinesassay developmentefficacy testingevaluation/testingimmunogenicitynovel vaccinespathogenproduct developmentsafety testing

项目摘要

项目成果

RANDI HORNBACK的其他基金

相似基金

相关文献

中文摘要
翻译
传染病疫苗和其他生物制品评估和测试服务(ETS)合同提供从早期可行性研究到I/II阶段材料生产的各种产品开发服务，包括分析开发、免疫原性和有效性测试、临床和非临床样本测试以及安全和毒性测试。这些服务将促进开发和引入新的疫苗和生物制品，以应对生物恐怖主义、抗药性病原体以及新出现和重新出现的传染病的潜在病原体。
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against potential agents of bioterrorism, drug-resistant pathogens, and emerging and re-emerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data